(Q44343992)

2 December 2017

title

Antibodies to advanced glycation end products in children with diabetes mellitus (English)

1 reference

2 December 2017

1 reference

Nicoloff G

1

1 reference

2 December 2017

Baydanoff S

series ordinal

2

1 reference

2 December 2017

Petrova Ch

series ordinal

3

1 reference

2 December 2017

Christova P

series ordinal

4

1 reference

2 December 2017

publication date

1 July 2002

1 reference

2 December 2017

published in

Vascular Pharmacology

1 reference

2 December 2017

volume

39

1 reference

2 December 2017

issue

1-2

1 reference

2 December 2017

page(s)

39-45

1 reference

Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Determination of anti-AGE antibodies in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Glycation products and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Lilly Lecture 1993. Glycation and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Advanced protein glycosylation in diabetes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Advanced glycosylation: chemistry, biology, and implications for diabetes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Advanced glycation end products, oxidant stress and vascular lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Oxidation of glycated proteins: age-dependent accumulation of N epsilon-(carboxymethyl)lysine in lens proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Differential expression of receptors for advanced glycation end products on monocytes in patients with IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Increase in crosslinking of nonenzymatically glycosylated collagen induced by products of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Non-enzymatic glycosylation and the chronic complications of diabetes: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Crosslines A and B as candidates for the fluorophores in age- and diabetes- related cross-linked proteins, and the diacetates produced by Maillard reaction of a-N-acetyl-L-lysine with D-glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Role of 12-lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Relationship between elastin-derived peptides and the development of microvascular complications: a longitudinal study in children with Type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Detection of serum collagen type IV in children with type 1 (insulin-dependent) diabetes mellitus--a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Advanced glycation end-products: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Atherogenesis and advanced glycation: promotion, progression, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Advanced glycation end-products and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

New biomarkers of Maillard reaction damage to proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900248-3

7 January 2021

10.1016/S1537-1891(02)00248-3

Identifiers

DOI

1 reference

2 December 2017

1 reference